Winter P M, Poptani H, Bansal N
Department of Radiology, The University of Pennsylvania, Philadelphia 19104, USA.
Cancer Res. 2001 Mar 1;61(5):2002-7.
The effects of chemotherapy [25 mg/kg 1,3-bis(2-chloroethyl)-1-nitrosourea administered with a single i.p. injection] on cellular energetics by 31P nuclear magnetic resonance (NMR) spectroscopy, total tissue sodium by single-quantum (SQ) 23Na NMR spectroscopy, and intracellular sodium by triple-quantum-filtered (TQF) 23Na NMR spectroscopy were studied in the s.c. 9L glioma. Animals were studied by NMR 2 days before therapy and 1 and 5 days after therapy. Destructive chemical analysis was also performed 5 days after therapy to validate the origin of changes in SQ and TQF 23Na signals. One day after treatment, there was no significant difference between control and treated tumors in terms of tumor size or 23Na and 31P spectral data. Five days after therapy, treated tumors had 28 +/- 16% (P < 0.1) lower SQ 23Na signal intensity, 46 +/- 20% (P < 0.05) lower TQF 23Na signal intensity, 125 +/- 51% (P < 0.05) higher ATP:Pi ratio, 186 +/- 69% (P < 0.05) higher phosphocreatine:Pi ratio, and 0.17 +/- 0.06 pH units (P < 0.05) higher intracellular pH compared with control tumors. No significant differences in TQF 23Na relaxation times were seen between control and treated tumors at any time point. Destructive chemical analysis showed that the relative extracellular space of control and treated tumors was identical, but the treated tumors had 21 +/- 8% (P < 0.05) lower total tissue Na+ concentration and 60 +/- 24% (P < 0.05) lower intracellular Na+ concentration compared with the controls. The higher phosphocreatine:Pi and ATP:Pi ratios after 1,3-bis(2-chloroethyl)-1-nitrosourea treatment indicate improved bioenergetic status in the surviving tumor cells. The decrease in SQ and multiple-quantum-filtered 23Na signal intensity was largely attributable to a decrease in Na(i)+ because the treatment did not change the relative extracellular space. The improved energy metabolism could decrease the intracellular concentration of Na+ by increasing the activity of Na+-K+-ATPase and decreasing the activity of Na+/H+. Although both 23Na and 31P spectra were consistent with improved cellular metabolism in treated tumors, the 23Na methods may be better suited for monitoring response to therapy because of higher signal:noise ratio and ease of imaging the single 23Na resonance.
采用31P核磁共振(NMR)波谱技术研究了化疗[腹腔注射1,3 - 双(2 - 氯乙基)-1 - 亚硝基脲,剂量为25 mg/kg]对皮下接种9L胶质瘤细胞能量代谢的影响,采用单量子(SQ)23Na NMR波谱技术研究了总组织钠含量,采用三量子滤波(TQF)23Na NMR波谱技术研究了细胞内钠含量。在治疗前2天以及治疗后1天和5天对动物进行NMR检测。治疗后5天还进行了破坏性化学分析,以验证SQ和TQF 23Na信号变化的来源。治疗后1天,对照肿瘤和治疗肿瘤在肿瘤大小、23Na和31P光谱数据方面无显著差异。治疗后5天,与对照肿瘤相比,治疗肿瘤的SQ 23Na信号强度降低了28±16%(P < 0.1),TQF 23Na信号强度降低了46±20%(P < 0.05),ATP:Pi比值升高了125±51%(P < 0.05),磷酸肌酸:Pi比值升高了186±69%(P < 0.05),细胞内pH升高了0.17±0.06个pH单位(P < 0.05)。在任何时间点,对照肿瘤和治疗肿瘤的TQF 23Na弛豫时间均无显著差异。破坏性化学分析表明,对照肿瘤和治疗肿瘤的相对细胞外空间相同,但与对照相比,治疗肿瘤的总组织Na+浓度降低了21±8%(P < 0.05),细胞内Na+浓度降低了60±24%(P < 0.05)。1,3 - 双(2 - 氯乙基)-1 - 亚硝基脲治疗后较高的磷酸肌酸:Pi和ATP:Pi比值表明存活肿瘤细胞的生物能量状态得到改善。SQ和多量子滤波23Na信号强度的降低主要归因于细胞内Na+(Na(i)+)的减少,因为治疗并未改变相对细胞外空间。改善的能量代谢可通过增加Na+-K+-ATP酶的活性和降低Na+/H+的活性来降低细胞内Na+浓度。尽管23Na和31P光谱均与治疗肿瘤中细胞代谢的改善一致,但由于23Na方法具有更高的信噪比且易于对单一23Na共振进行成像,因此可能更适合监测治疗反应。